Alzheimer's disease (AD) is characterized by the presence of amyloid β (Aβ) plaques and neurofiber tau tangles (58), Lim et al. (59) developed fluorescently labeled optogenetically activated Aβ peptides that can oligomerize in vitro during light exposure. This evidence concerns the gene MAPT and Alzheimer disease.